Eptifibatide Injection, Solution
Product Images NDC 67457-631

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Eptifibatide (NDC 67457-631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Chemical structure diagram of the active ingredient eptifibatide, showing its molecular framework with peptide bonds and specific side chains.*

FDA Label Image

Figure 2 (Image 02)

A line graph comparing the percent of patients with events over 30 days between two treatments: Eptifibatide (solid line) and Placebo (dashed line). The x-axis represents time in days from 0 to 30, and the y-axis shows the percent of patients with events, ranging from 0 to 16%. The graph illustrates event rates for Eptifibatide and Placebo treatments over time.*

FDA Label Image

Carton-20 mg (Image 03)

The packaging label for Eptifibatide Injection, 20 mg/10 mL (2 mg/mL) by Mylan Institutional LLC. The label states it is a sterile, single-dose vial intended for intravenous use only. It includes storage instructions, contents per mL, and manufacturing details indicating the product is made in India. The label features barcodes, usage warnings, and Mylan branding.*

FDA Label Image

Carton-75 mg (Image 04)

Packaging label for Eptifibatide Injection 75 mg/100 mL (0.75 mg/mL) single-dose vial by Mylan Institutional LLC. The label includes contents, storage instructions, and usage notes for intravenous use only. It features the NDC 67457-631-10, barcode, and manufacturer details with a blue and white color scheme.*

FDA Label Image

Carton-200 mg (Image 05)

Label for Eptifibatide Injection 200 mg/100 mL (2 mg/mL) single-dose vial by Mylan Institutional LLC. The label states the product is for intravenous use only and sterile. Storage instructions, contents including 2 mg eptifibatide per mL, and packaging details are also included, with barcodes and the manufacturer's address in Morgantown, WV, USA. The vial is intended for weight-adjusted infusion.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.